Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-16

Clinical Trial Update: Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes

View source ↗

Summary

A completed clinical trial evaluated the safety and efficacy of adding sitagliptin to ongoing insulin therapy in people with Type 2 diabetes. The study assessed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)

Snippet

Sponsor: Kanagawa Physicians Association | Conditions: Type 2 Diabetes | Status: COMPLETED